Diabetic nephropathy

Mark E. Molitch; Ralph A. DeFronzo; Marion J. Franz; William F. Keane; Carl Erik Mogensen; Hans Henrik Parving; Michael W. Steffes

doi:10.2337/diacare.25.2007.s85

Diabetic nephropathy

Mark E. Molitch, Ralph A. DeFronzo, Marion J. Franz, William F. Keane, Carl Erik Mogensen, Hans Henrik Parving, Michael W. Steffes

Laboratory Medicine and Pathology

Research output: Contribution to journal › Review article › peer-review

208 Scopus citations

Abstract

Annual screening for microalbuminuria will allow the identification of patients with nephropathy at a point very early in its course. Improving glycemic control, aggressive antihypertensive treatment, and the use of ACE inhibitors or ARBs will slow the rate of progression of nephropathy. In addition, protein restriction and other treatment modalities such as phosphate lowering may have benefits in selected patients.

Original language	English (US)
Pages (from-to)	S85-S89
Journal	Diabetes care
Volume	25
Issue number	SUPPL. 1
DOIs	https://doi.org/10.2337/diacare.25.2007.s85
State	Published - Jan 2002

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.2337/diacare.25.2007.s85

OpenUrl availability

Full text

Cite this

@article{d04c0cdf3e1544c7816175ea51893a63,

title = "Diabetic nephropathy",

abstract = "Annual screening for microalbuminuria will allow the identification of patients with nephropathy at a point very early in its course. Improving glycemic control, aggressive antihypertensive treatment, and the use of ACE inhibitors or ARBs will slow the rate of progression of nephropathy. In addition, protein restriction and other treatment modalities such as phosphate lowering may have benefits in selected patients.",

author = "Molitch, {Mark E.} and DeFronzo, {Ralph A.} and Franz, {Marion J.} and Keane, {William F.} and Mogensen, {Carl Erik} and Parving, {Hans Henrik} and Steffes, {Michael W.}",

year = "2002",

month = jan,

doi = "10.2337/diacare.25.2007.s85",

language = "English (US)",

volume = "25",

pages = "S85--S89",

journal = "Diabetes care",

issn = "0149-5992",

publisher = "American Diabetes Association Inc.",

number = "SUPPL. 1",

}

TY - JOUR

T1 - Diabetic nephropathy

AU - Molitch, Mark E.

AU - DeFronzo, Ralph A.

AU - Franz, Marion J.

AU - Keane, William F.

AU - Mogensen, Carl Erik

AU - Parving, Hans Henrik

AU - Steffes, Michael W.

PY - 2002/1

Y1 - 2002/1

N2 - Annual screening for microalbuminuria will allow the identification of patients with nephropathy at a point very early in its course. Improving glycemic control, aggressive antihypertensive treatment, and the use of ACE inhibitors or ARBs will slow the rate of progression of nephropathy. In addition, protein restriction and other treatment modalities such as phosphate lowering may have benefits in selected patients.

AB - Annual screening for microalbuminuria will allow the identification of patients with nephropathy at a point very early in its course. Improving glycemic control, aggressive antihypertensive treatment, and the use of ACE inhibitors or ARBs will slow the rate of progression of nephropathy. In addition, protein restriction and other treatment modalities such as phosphate lowering may have benefits in selected patients.

UR - http://www.scopus.com/inward/record.url?scp=23944511753&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23944511753&partnerID=8YFLogxK

U2 - 10.2337/diacare.25.2007.s85

DO - 10.2337/diacare.25.2007.s85

M3 - Review article

AN - SCOPUS:23944511753

SN - 0149-5992

VL - 25

SP - S85-S89

JO - Diabetes care

JF - Diabetes care

IS - SUPPL. 1

ER -

Diabetic nephropathy

Abstract

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this